Transcript
Pharmaceutical Narrator (0:00)
Eczema isn't always obvious, but it's real, and so is the relief from Ebglis. After an initial dosing phase, about 4 in 10 people taking EBGLIS achieved itch relief and clear or almost clear skin at 16 weeks, and most of those people maintained skin that's still more clear at one year with monthly dosing.
Pharmaceutical Narrator (0:18)
EBGLIS Librekizumab LBKZ, a 250 milligram per 2 milliliter injection, is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema, also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals, or who cannot use topical therapies. EBGLIS can be used with or without topical corticosteroids. Don't use if you're allergic to Epglis. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with Epglis. Before starting Epglis, tell your doctor if you have a parasitic infection searching for real relief.
Pharmaceutical Narrator (0:52)
Ask your doctor about epglis and visit epgliss.lily.com or call 1-800-lilyrx or 1-800-545-5979.
Public Investing Sponsor (1:00)
Support for the show comes from Public, the investing platform for who Take it seriously. On public you can build a multi asset portfolio of stocks, bonds, options, crypto and now generated assets which allow you to turn any idea into an investable index. With AI, it all starts with your prompt. From renewable energy companies with high free cash flow to semiconductor suppliers growing revenue over 20% year over year, you can literally type any prompt and put the AI to work. It screens thousands of stocks, builds a one of a kind index and lets you back test it against the S&P 500. Then you can invest in a few clicks. Generated assets are like ETFs with infinite possibilities, completely customizable and based on your thesis, not someone else's. Go to public.com podcast and earn an uncapped 1% bonus when you transfer your portfolio. That's public.com podcast paid for by Public Investing Brokerage Services by Open to the Public Investing Inc. Member FINRA and SIPC Advisory Services by Public Advisors llc. SEC Registered Advisor Generated Assets is an interactive analysis tool. Output is for informational purposes only and is not an investment recommendation or advice. Complete disclosures available@public.com Disclosures lost support through
Orderly Meds Sponsor (2:01)
telehealth, but it feels overwhelming and rushed. Check out orderlymeds.com now. OrderlyMeds was built to be different. Here you connect with real doctors who take the time to understand your goals, review your eligibility, and guide you through a plan that's right for you. Orderly Meds provides access to proven GLP1 medications like semaglutide and Tirzepatide, including both name brand options and personalized compound versions when appropriate. So you have choices backed by clinical oversight, not guesswork. It's a simpler, more supportive telehealth experience design around people who want clarity, care and confidence in their weight loss journey. And your medication is delivered directly to your home in discreet packaging so your experience stays private from start to finish. Do your research, ask the right questions, then visit orderlymeds.com podcast for an exclusive offer. Again, that's orderlymeds.com podcast. Individual results may vary. Not medical advice, eligibility required. See site for details.
